The in vitro diagnostics packaging market is expected to grow from USD 9.07 billion in 2025 to USD 14.25 billion by 2034, with a CAGR of 5.14% during this period. The growth is driven by the rising demand for packaging and local production of diagnostic tests as economic conditions improve. The increasing prevalence of chronic diseases like autoimmune diseases, cancer, and diabetes has boosted the focus on patient safety. Additionally, the growing demand for home healthcare and self-testing kits is contributing to the markets development.
In Vitro Diagnostics Packaging Market Key Players
Latest Announcements by Market Leaders
- In January 2025, CEO of Akoya, Brian McKelligon expressed, “Our spatial phenotyping technology and PhenoImager platform are demonstrating robust diagnostic capabilities for patient selection. Our partnership with Argonaut is centered around delivering high-quality IVD products to our clients, manufactured under strict cGMP and ISO 13485:2016 requirements. Argonauts deep expertise and reliable systems make them an invaluable partner as we scale to meet the demand of the market.”
Recent Development
- In January 2025, Ampacet has announced the launch of ProVital + LaserMark. It is a portfolio of masterbatches designed for high-contrast laser marking using Nd:YAG on medical devices, in-vitro diagnostic equipment and packaging systems.
- In January 2025, the Spatial Biology Company®, announced today that Argonaut will act as the manufacturing partner for Akoya IVD assays currently in development.
Become a valued research partner with us, please feel free to contact us at sales@towardspackaging.com
